Renaissance Technologies’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Sell |
165,188
-99,800
| -38% | -$399K | ﹤0.01% | 2697 |
|
|
2025
Q1 | $843K | Sell |
264,988
-125,700
| -32% | -$400K | ﹤0.01% | 2515 |
|
|
2024
Q4 | $2.09M | Buy |
390,688
+4,100
| +1% | +$21.9K | ﹤0.01% | 2022 |
|
|
2024
Q3 | $2.04M | Sell |
386,588
-177,344
| -31% | -$936K | ﹤0.01% | 2007 |
|
|
2024
Q2 | $1.03M | Sell |
563,932
-73,100
| -11% | -$133K | ﹤0.01% | 2300 |
|
|
2024
Q1 | $1.13M | Buy |
637,032
+49,600
| +8% | +$88.3K | ﹤0.01% | 2408 |
|
|
2023
Q4 | $1.03M | Buy |
587,432
+165,689
| +39% | +$292K | ﹤0.01% | 2381 |
|
|
2023
Q3 | $616K | Sell |
421,743
-67,930
| -14% | -$99.2K | ﹤0.01% | 2624 |
|
|
2023
Q2 | $1.12M | Sell |
489,673
-16,359
| -3% | -$37.5K | ﹤0.01% | 2399 |
|
|
2023
Q1 | $460K | Sell |
506,032
-142,600
| -22% | -$130K | ﹤0.01% | 2927 |
|
|
2022
Q4 | $551K | Sell |
648,632
-326,887
| -34% | -$278K | ﹤0.01% | 2902 |
|
|
2022
Q3 | $798K | Buy |
975,519
+12,587
| +1% | +$10.3K | ﹤0.01% | 2633 |
|
|
2022
Q2 | $953K | Buy |
962,932
+61,800
| +7% | +$61.2K | ﹤0.01% | 2755 |
|
|
2022
Q1 | $1.48M | Sell |
901,132
-142,600
| -14% | -$234K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $2.52M | Buy |
1,043,732
+429,362
| +70% | +$1.03M | ﹤0.01% | 1969 |
|
|
2021
Q3 | $2.97M | Sell |
614,370
-43,700
| -7% | -$212K | ﹤0.01% | 1790 |
|
|
2021
Q2 | $1.76M | Sell |
658,070
-5,400
| -0.8% | -$14.4K | ﹤0.01% | 2342 |
|
|
2021
Q1 | $2.04M | Sell |
663,470
-133,600
| -17% | -$411K | ﹤0.01% | 2211 |
|
|
2020
Q4 | $2.84M | Sell |
797,070
-77,930
| -9% | -$277K | ﹤0.01% | 1923 |
|
|
2020
Q3 | $3.51M | Sell |
875,000
-156,900
| -15% | -$629K | ﹤0.01% | 1780 |
|
|
2020
Q2 | $2.81M | Buy |
1,031,900
+101,200
| +11% | +$275K | ﹤0.01% | 1980 |
|
|
2020
Q1 | $1.96M | Buy |
930,700
+24,500
| +3% | +$51.7K | ﹤0.01% | 2058 |
|
|
2019
Q4 | $4.93M | Buy |
906,200
+54,422
| +6% | +$296K | ﹤0.01% | 1863 |
|
|
2019
Q3 | $2.56M | Buy |
851,778
+18,680
| +2% | +$56.2K | ﹤0.01% | 2149 |
|
|
2019
Q2 | $3.12M | Buy |
833,098
+51,398
| +7% | +$192K | ﹤0.01% | 2100 |
|
|
2019
Q1 | $3.14M | Buy |
781,700
+119,400
| +18% | +$480K | ﹤0.01% | 2085 |
|
|
2018
Q4 | $2.43M | Buy |
662,300
+265,400
| +67% | +$974K | ﹤0.01% | 2125 |
|
|
2018
Q3 | $3.41M | Buy |
396,900
+72,000
| +22% | +$618K | ﹤0.01% | 2020 |
|
|
2018
Q2 | $3.57M | Sell |
324,900
-101,800
| -24% | -$1.12M | ﹤0.01% | 1972 |
|
|
2018
Q1 | $4.92M | Buy |
426,700
+192,500
| +82% | +$2.22M | 0.01% | 1820 |
|
|
2017
Q4 | $2.43M | Buy |
234,200
+39,900
| +21% | +$413K | ﹤0.01% | 2230 |
|
|
2017
Q3 | $3.1M | Buy |
194,300
+57,200
| +42% | +$912K | ﹤0.01% | 2057 |
|
|
2017
Q2 | $1.66M | Buy |
137,100
+79,300
| +137% | +$960K | ﹤0.01% | 2344 |
|
|
2017
Q1 | $1.2M | Buy |
+57,800
| New | +$1.2M | ﹤0.01% | 2474 |
|